CARA NELSON: Open Payments
NPI 1386267136 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 30 payments from 15 companies in 2025. Trend: 2023 $782 · 2024 $1,269 · 2025 $1,046
Food & beverage: $902Education: $144
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 4 | $339 |
| United Therapeutics Corporation | 2 | $120 |
| GENZYME CORPORATION | 4 | $99 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $32 |
| Verona Pharma, Inc. | 1 | $30 |
| Pulmonx Corporation | 1 | $29 |
Products named: UPTRAVI, DUPIXENT, TYVASO, OPSUMIT, NUCALA, LUMRYZ, TRELEGY ELLIPTA, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
